Griffin Asset Management, Inc. Pfizer Inc Transaction History

Griffin Asset Management, Inc.

$834 Million
Q4 2024

A detailed history of Griffin Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 82,118 shares of PFE stock, worth $2.18 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

82,118

Previous 94,607 13.2%

Holding current value

$2.18 Million

Previous $2.74 Million 20.42%

% of portfolio

0.26%

Previous 0.31%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	SELL	$24.8 - $30.19 $309,727 - $377,042	-12,489 Reduced 13.2%	82,118 $2.18 Million
Q3 2024 Oct 15, 2024	BUY	$27.7 - $31.39 $225,422 - $255,451	8,138 Added 9.41%	94,607 $2.74 Million
Q2 2024 Jul 23, 2024	BUY	$25.26 - $29.6 $466,804 - $547,008	18,480 Added 27.18%	86,469 $2.42 Million
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $205,644 - $236,145	7,943 Added 13.23%	67,989 $1.89 Million
Q4 2023 Jan 19, 2024	BUY	$26.13 - $33.94 $181,342 - $235,543	6,940 Added 13.07%	60,046 $1.73 Million
Q3 2023 Oct 19, 2023	BUY	$32.09 - $37.51 $2,567 - $3,000	80 Added 0.15%	53,106 $1.76 Million
Q2 2023 Aug 01, 2023	SELL	$36.12 - $41.79 $770,728 - $891,715	-21,338 Reduced 28.69%	53,026 $1.94 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $22,924 - $29,844	-582 Reduced 0.78%	74,364 $3.03 Million
Q4 2022 Jan 20, 2023	BUY	$41.75 - $54.5 $97,945 - $127,857	2,346 Added 3.23%	74,946 $0
Q3 2022 Oct 19, 2022	BUY	$43.76 - $53.42 $11,946 - $14,583	273 Added 0.38%	72,600 $3.18 Million
Q2 2022 Jul 19, 2022	BUY	$46.53 - $55.17 $48,809 - $57,873	1,049 Added 1.47%	72,327 $3.79 Million
Q1 2022 Apr 12, 2022	BUY	$45.75 - $56.69 $413,625 - $512,534	9,041 Added 14.53%	71,278 $3.69 Million
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $329,196 - $487,978	7,967 Added 14.68%	62,237 $3.68 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $206,101 - $264,755	5,251 Added 10.71%	54,270 $2.33 Million
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $95,771 - $108,493	-2,667 Reduced 5.16%	49,019 $1.92 Million
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $90,858 - $102,470	-2,713 Reduced 4.99%	51,686 $1.87 Million
Q4 2020 Jan 27, 2021	SELL	$33.47 - $42.56 $54,723 - $69,585	-1,635 Reduced 2.92%	54,399 $2 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $88,074 - $103,331	2,774 Added 5.21%	56,034 $2.06 Million
Q2 2020 Aug 18, 2020	SELL	$30.12 - $36.54 $27,861 - $33,799	-925 Reduced 1.71%	53,260 $1.74 Million
Q1 2020 May 18, 2020	SELL	$27.03 - $38.62 $309,574 - $442,314	-11,453 Reduced 17.45%	54,185 $1.77 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $19,587 - $22,229	595 Added 0.91%	65,638 $2.57 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $904,619 - $1.17 Million	-27,843 Reduced 29.98%	65,043 $2.34 Million
Q2 2019 Aug 19, 2019	BUY	$36.98 - $41.52 $11,907 - $13,369	322 Added 0.35%	92,886 $4.02 Million
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $46,537 - $51,129	-1,241 Reduced 1.32%	92,564 $3.93 Million
Q4 2018 Mar 01, 2019	BUY	$38.47 - $43.86 $7,309 - $8,333	190 Added 0.2%	93,805 $4.1 Million
Q3 2018 Nov 19, 2018	BUY	$34.47 - $41.81 $192,825 - $233,885	5,594 Added 6.36%	93,615 $4.13 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $193,757 - $206,564	-5,875 Reduced 6.26%	88,021 $3.19 Million
Q1 2018 May 16, 2018	BUY	$31.91 - $37.02 $200,873 - $233,040	6,295 Added 7.19%	93,896 $3.33 Million
Q4 2017 Feb 20, 2018	BUY	$33.26 - $35.29 $1.04 Million - $1.1 Million	31,210 Added 55.35%	87,601 $3.17 Million
Q3 2017 Nov 15, 2017	BUY	$31.0 - $34.15 $1.04 Million - $1.14 Million	33,524 Added 146.6%	56,391 $2.01 Million
Q2 2017 Aug 29, 2017	BUY	N/A	22,867	22,867 $768,000

Others Institutions Holding PFE

# of Institutions

3,228

Shares Held

3.62B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Pfizer Inc Transaction History